Ascendis Pharma grants 31,710 employee warrants at $208.71 per share

Ascendis Pharma A/S (NASDAQ:ASND), a $20.61 billion market cap biotech company with strong liquidity metrics, disclosed Wednesday that its board of directors has granted a total of 31,710 warrants to certain employees. According to InvestingPro data, the company maintains a healthy balance sheet with a current ratio of 5.02, indicating robust financial flexibility. Each warrant entitles the holder to subscribe for one ordinary share of the company at an exercise price of $208.71 per share, which is equal to the closing price of the company’s American Depositary Shares on the date of the grant.

The warrants were issued under Appendix 1a to the company’s Articles of Association. According to the company’s statement, 25% of the warrants will vest on the one-year anniversary of the grant date, with the remaining 75% vesting in equal monthly installments over the following three years, subject to continued employment. The warrants may vest earlier if certain exit events occur.

Following this grant, Ascendis Pharma reported that warrants to subscribe for an additional 1,794,273 shares remain available for future grants under the Articles of Association.

This information is based on a press release statement included in the company’s filing with the U.S. Securities and Exchange Commission.

In other recent news, Scorpius Holdings has entered into a new financing agreement, issuing a non-convertible promissory note valued at $500,083 with a 5% annual interest rate. This note is set to mature by October 31, 2025, or upon a defined corporate event. Ascendis Pharma has increased its share capital following the exercise of outstanding warrants, resulting in the issuance of 543,748 new ordinary shares at approximately $97.45 per share. This change was registered with the Danish Business Authority, reflecting an increase in the company’s nominal share capital.

onsemi has announced an agreement to acquire Aura Semiconductor’s Vcore power technologies, aiming to bolster its power management solutions for AI data centers. The deal is expected to close in the fourth quarter of 2025, pending customary conditions. PHP Ventures Acquisition Corp. has extended its deadline for completing a business combination to October 16, 2025, by depositing $4,770.70 into its trust account. This extension allows the company more time to pursue potential mergers or acquisitions. Meanwhile, semiconductor stocks, including onsemi, have faced declines following China’s investigations into the US chip sector amid ongoing trade discussions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.